Brief: Aadi Bioscience Announces Exploratory Biomarker Data From Patients In Its Ampect Trial And Expanded Access Program To Be Presented At 2022 Asco Annual Meeting

Whitehawk Therapeutics

27/05/2022 24:54

May 26 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES EXPLORATORY BIOMARKER DATA FROM
PATIENTS IN ITS AMPECT TRIAL AND EXPANDED ACCESS PROGRAM TO BE
PRESENTED AT 2022 ASCO ANNUAL MEETING

Source text for Eikon:  ID:nGNX991tv5 
Further company coverage:  AADI.O 

 ((Reuters.Briefs@thomsonreuters.com;))